Clinical trial
Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients
NCT01843647
Study timeline
Study start (unknown)2013-04-01Date precision: month
Registry last updated2015-07-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small-cell Lung Cancerunresolved
Interventions
IcotinibDRUG
ChemotherapyDRUG
Sponsors & collaborators
Betta Pharmaceuticals Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01843647 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.